Clinical trial: A novel high‐dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500‐mg suppository thrice daily in active ulcerative proctitis
暂无分享,去创建一个
M. Vieth | M. Stolte | I. Cascorbi | K. Dilger | R. Greinwald | T. Andus | A. Dorofeyev | R. Mohrbacher | T. Mikhailova | A. Baranovsky | A. Kocjan | M. Müser | T. D. Zvyagintseva | Y. Lozynskyy | Ralf Mohrbacher